CHANGES IN PHARMACOLOGICAL TREATMENT PATTERN FOR TYPE 2 DIABETES IN FIVE YEARS: BEFORE AND AFTER THE INTRODUCTION OF DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITOR AT A DIABETES SPECIALIST CLINIC IN TOKYO

被引：0
|
作者：
Watanabe, Y. [1 ]
Takayama, C. [2 ]
Asada, Y. [2 ]
Mori, T. [2 ]
Kawagoe, Y. [1 ]
Fujii, H. [1 ]
Miyakawa, T. [1 ]
机构：
[1] Tama Ctr Mirai Clin, Internal Med, Tokyo, Japan
[2] Yamato Prescript Ctr, Tokyo, Japan
来源：
DIABETES RESEARCH AND CLINICAL PRACTICE | 2014年 / 106卷
关键词：
D O I：
10.1016/S0168-8227(14)70492-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PO198
引用
收藏
页码：S148 / S149
页数：2
相关论文
共 50 条
  • [1] Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
    不详
    JOURNAL OF DIABETES, 2009, 1 (01) : 6 - 7
  • [2] Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
    Richter, B.
    Bandeira-Echtler, E.
    Bergerhoff, K.
    Lerch, C. L.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (02):
  • [3] EFFICACY AND SAFETY OF DIPEPTIDYL PEPTIDASE-4 (DPP-4) INHIBITOR IN HEMODIALYSIS PATIENTS WITH TYPE 2 DIABETES
    Abe, Masanori
    Okada, Kazuyoshi
    Oikawa, Osamu
    Maruyama, Noriaki
    Furukawa, Tetsuya
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 216 - 216
  • [4] Dipeptidyl peptidase IV (DPP-4) inhibition as a treatment for type 2 diabetes
    Thornberry, Nancy A.
    TUMOR BIOLOGY, 2007, 28 : 26 - 26
  • [5] Effects of dipeptidyl peptidase-4 (DPP-4) inhibition on angiogenesis and hypoxic injury in type 2 diabetes
    Fiordaliso, Fabio
    Maggioni, Serena
    Balconi, Giovanna
    Schiarea, Silvia
    Corbelli, Alessandro
    De Luigi, Ada
    Figliuzzi, Marina
    Antoniou, Xenia
    Chiabrando, Chiara
    Masson, Serge
    Cervo, Luigi
    Latini, Roberto
    LIFE SCIENCES, 2016, 154 : 87 - 95
  • [6] Effects of dipeptidyl peptidase-4 (DPP-4) inhibition on angiogenesis and hypoxic injury in type 2 diabetes
    Fiordaliso, F.
    Balconi, G.
    Mohammed, S. A. A.
    Maggioni, M. S.
    Biondi, A.
    Masson, S.
    Cervo, L.
    Latini, R.
    CARDIOVASCULAR RESEARCH, 2010, 87 : S101 - S101
  • [7] Vildagliptin, a dipeptidyl peptidase-4 inhibitor, for the treatment of type 2 diabetes
    Stein, Stephanie A.
    Lamos, Elizabeth M.
    Davis, Stephen N.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (04) : 599 - 608
  • [8] Linagliptin, a dipeptidyl peptidase-4 inhibitor for the treatment of type 2 diabetes
    Tiwari, Atul
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2009, 10 (10) : 1091 - 1104
  • [9] Dipeptidyl peptidase 4 (DPP-4) as a target for type 2 diabetes.
    Hughes, TE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2004, 228 : U944 - U944
  • [10] A META-ANALYSIS OF EFFICACY AND SAFETY OF DIPEPTIDYL PEPTIDASE-4 [DPP-4] INHIBITORS IN TYPE 2 DIABETES
    Park, H.
    Park, C.
    Kim, Y.
    Rascati, K. L.
    VALUE IN HEALTH, 2012, 15 (04) : A172 - A172
12345